Navigation Links
Study Focuses on Women's Health After Breast Cancer

The “Women’s Health After Breast Cancer” initiative at Roswell Park Cancer Institute (RPCI) is investigating factors that may affect women’s health //after they are diagnosed with breast cancer, with a focus on both quality of life and prevention of cancer recurrence.

The comprehensive study, under the direction of Chi-Chen Hong, PhD, and Christine Ambrosone, PhD, Department of Epidemiology, RPCI, will examine the combined impact of cancer treatment, genetic makeup, physiological changes, lifestyle habits, diet, physical activity, emotional well being, and social support as factors that can affect the health of women with breast cancer and be predictive of risk for recurrence.

Weight gain – the initial research focus – occurs in 50 to 95 percent of early stage breast cancer patients who receive chemotherapy after surgery and/or radiation therapy, and has been associated with a poorer prognosis.

The prospective study will follow 600 early stage breast cancer patients from diagnosis, through treatment and after treatment to identify modifiable risk factors for weight gain, women who are most susceptible to weight gain during and after treatment for breast cancer, and to investigate the influence of weight gain on the risk of recurrence.

Data on hormone levels, menopausal status, body composition, diet, physical activity, psychological variables, genetic makeup will be collected at baseline, at six months and annually for two years. Mammographic density levels will be monitored annually as an indicator of breast cancer risk. This is believed to be the first study to investigate the role of hormonal changes and genetic variants in weight gain in these patients.

A study of alterations in weight, body composition and fat distribution among early stage breast cancer patients will provide insights into the mechanisms by which weight gain influences prognosis and targets for prevention of recurrence these patient s.

(Source: Newswse)
'"/>




Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... For Coast ... hygienist Suzan Sweeney, RDH, and dental assistant Terrell Moore shortly before 7 a.m. to ... dozens of dental professionals, donating their time and skills to help hundreds of uninsured ...
(Date:2/12/2016)... DC (PRWEB) , ... February 12, 2016 , ... ... “Managing High-Cost Drug Categories: Strategies for Health Plans and PBMs,” an upcoming Feb. ... to maintain affordability and access in big-dollar therapeutic categories, such as the $1,000-per-pill ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Healthcare careers in ... five most searched jobs via the website of healthcare staffing leader Aureus Medical Group ... travel nurse jobs , travel therapy positions and in travel and direct ...
(Date:2/12/2016)... ... ... Basketball is a game for everyone, not just those who can hear! ... translation is featured in the top right of the screen. Every technique that is ... sign language translator to teach kids the game and how to be as active ...
(Date:2/11/2016)... ... February 12, 2016 , ... Fitbody Personal Training offers ... fun and exciting way to get fit and healthy. Located in Phoenixville, PA, the ... for a class designed for horseback riders who want to lose weight and tone ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Feb. 12, 2016  Apellis Pharmaceuticals, ... a $47.1 million Series D preferred stock ... Management, Hillhouse Capital Group and venBio Global ... Investments, AJU IB Investment, and Epidarex Capital. The ... to further advance clinical trials in the ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary ... and future adoption patterns on the usage of liquid ... the following: - Timeframe of liquid biopsy ... ctDNA, cfDNA and Evs—by organization type - Sample inflow ... types: blood, saliva, stool, serum, and so on. - ...
(Date:2/11/2016)... 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ), ... lives of pets, today announced the submission to FDA ... Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive ... Zimeta for the control of pyrexia (fever) in horses ... --> --> The Chemistry, Manufacturing, and ...
Breaking Medicine Technology: